NEW YORK (360Dx) – Researchers at the University of Central Lancashire, in Preston, UK, said that they have achieved accurate results using infrared spectroscopy to identify Alzheimer's disease and other forms of dementia in patients' blood.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.